Back to news archive
News 2022-01-03

Gradientech closes $8.3m investment round

Gradientech announces closure of a financing round totalling $8.3 million (SEK 75.3 million). The round was executed by a combination of existing shareholders and several new investors appointed by Swedish financial advisor Redeye. Lindahl acted as legal advisors.

Link to press-release

Gradientech is an ISO13485 certified company since 2017


Gradientech AB
Uppsala Science Park
SE-751 83 Uppsala

About Gradientech

Gradientech develops, manufactures and sells innovative microfluidic products for high-quality analysis of the behavior of cells and organisms in response to gradients of biomolecules. Our aim is to pioneer life science and healthcare.

Copyright © 2024 Gradientech. All rights reserved. Gradientech, QuickMIC and CellDirector are registered trademarks or trademarks of Gradientech AB.

Next-generation antimicrobial susceptibility testing

Take a look at our E-book